Introduction into the practice of medical ozone in combination with antiviral drugs for the treatment of women with herpes infection on the background of FPI

  • Resident of the magistracy of the 3rd course, Department 1-Obstetrics and Gynecology, Andijan State Medical Institute
  • Candidate of Medical Sciences, Associate Professor, Department 1-Obstetrics and Gynecology, Andijan State Medical Institute

DOI

https://doi.org/10.47689/2181-3663-vol2-iss5-pp32-35

Keywords

herpes infection , ozone therapy , miscarriage

Abstract

Herpetic infection caused by the herpes simplex virus (HSV) is one of the significant problems of modern health care. This is due to a sharp increase in the incidence, a wide range of clinical manifestations, the possibility of an asymptomatic course and a high contagiousness of the pathogen. The probability of intrauterine transmission of HSV, which significantly worsens perinatal outcomes, has been proven. Over 90% of people in the world are infected with HSV, and only 20% of it manifests itself clinically.

References

Voloshchuk I.N. Morphological bases and pathogenesis of placental insufficiency: dis. ... dr. honey. Sciences. Moscow, 2012. 298 p.

Khachaturova M.D., Fedorovich O.K., Novikova V.A. and other Features of the treatment of placental insufficiency in violations of the fetal-placental blood flow / Proceedings of the IX Russian Forum "Mother and Child". Moscow. 2017. S. 279-280.

Barry J.S., Rozance P.J., Anthony R.V. An animal model of placental insufficiency-induced intrauterine growth restriction. Semin Perinatol. 2008. Vol. 32. № 3. P. 225-230.

Black L.V., Maheshwari A. Disorders of the fetomaternal unit: hematologic manifestations in the fetus and neonate. Semin Perinatol. 2009. Vol. 33. № 1. P. 12-19.

Ergaz Z., Avgil M., Ornoy A. Intrauterine growth restriction-etiology and consequences: what do we know about the human situation and experimental animal models. Reprod Toxicol. 2015. Vol. 20. № 3. P. 301-322.

Glukhovets B.I., Rets lu.V. Fetal compensatory and abnormal reactions in fetoplacental insufficiency. Arkh Patol. 2008. Vol. 70. № 2. P. 59-62.

Bernstein DI, Bellamy AR, Hook EW et al. Epidemiology, clinical presentation and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women 35:599.

Xu F, Sternberg MR, Kottiri BJ et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 2006; 296: 9644. Workowski KA, Bolan GA, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Re-comm Rep 2015; 64:1

Downloads

174 134

Published

Introduction into the practice of medical ozone in combination with antiviral drugs for the treatment of women with herpes infection on the background of FPI

How to Cite

Abdurashidova , K. and Akhmedova , N. 2023. Introduction into the practice of medical ozone in combination with antiviral drugs for the treatment of women with herpes infection on the background of FPI . Preventive Medicine and Health. 2, 5 (Oct. 2023), 32–35. DOI:https://doi.org/10.47689/2181-3663-vol2-iss5-pp32-35.